Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).
Proc Natl Acad Sci U S A
; 115(43): E10119-E10126, 2018 10 23.
Article
in En
| MEDLINE
| ID: mdl-30297397
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
B7-H1 Antigen
/
Lung Neoplasms
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2018
Type:
Article